Lumexa Imaging Holdings, Inc.
LMRINasdaqCIK 2071288HealthcareFiscal year ends Dec 31
Reports and events: 16 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1314:54 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-348902 |
| 2026-08-1216:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-346813 |
| 2026-06-3017:08 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-290788 |
| 2026-06-1216:05 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-269379 |
| 2026-05-1216:15 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-219480 |
| 2026-05-1216:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-219415 |
| 2026-04-2816:36 ET | DEF 14A | Proxy statementPeriod 2026-06-10 | 0001193125-26-187316 |
| 2026-04-0917:11 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-26-149837 |
| 2026-03-3017:32 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-131907 |
| 2026-03-2606:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-124978 |
| 2026-03-0206:14 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-084047 |
| 2026-01-1506:48 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-013511 |
| 2025-12-1816:01 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-324774 |
| 2025-12-1216:01 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-317521 |
| 2025-12-0206:34 ET | S-1/A | Registration statement, amended | 0001193125-25-304460 |
| 2025-11-1716:24 ET | S-1 | Registration statement | 0001193125-25-284663 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. Listed shows no prices and gives no investment advice.